(Q34492360)

2 August 2017

1 reference

title

The antithrombotic and antiinflammatory mechanisms of action of aprotinin (English)

1 reference

2 August 2017

Landis RC

1

1 reference

2 August 2017

Asimakopoulos G

2

1 reference

2 August 2017

Poullis M

3

1 reference

2 August 2017

Haskard DO

4

1 reference

2 August 2017

Taylor KM

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

The Annals of Thoracic Surgery

2 August 2017

published in

1 reference

2 August 2017

volume

72

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

2169-2175

1 reference

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Effects of minimal-dose aprotinin on coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

The efficacy and safety of aprotinin use in cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin and vein graft occlusion--the controversy continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin can inhibit the proteolytic activity of thrombin. A fluorescence and an enzymatic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

How the protease thrombin talks to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Domains specifying thrombin–receptor interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Minimal sequence requirement of thrombin receptor agonist peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

PAR3 is a cofactor for PAR4 activation by thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Platelet preservation during cardiopulmonary bypass with aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

The platelet thrombin receptor and postoperative bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Inflammatory response to cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

SIRS--the systemic inflammatory response syndrome after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil CD11b up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Leukocyte integrin expression in patients undergoing cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Tissue destruction by neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Adhesion molecules--Part II: Blood vessels and blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD18-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Inhibition of neutrophil adhesion during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Elastase contributes to antigen-induced mucociliary dysfunction in ovine airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Effect of aprotinin on endothelial cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Differing effects of aprotinin and epsilon-aminocaproic acid on cytokine-induced inducible nitric oxide synthase expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Reduced transplant arteriosclerosis in plasminogen-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Vascular protease receptors: integrating haemostasis and endothelial cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902821-1

10.1016/S0003-4975(01)02821-1

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference